These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 3018111)

  • 41. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of collagen-induced fibrinogen binding to human platelets.
    Legrand C; Dubernard V; Nurden AT
    Biochim Biophys Acta; 1985 Feb; 812(3):802-10. PubMed ID: 3970909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor.
    Coller BS; Peerschke EI; Seligsohn U; Scudder LE; Nurden AT; Rosa JP
    J Lab Clin Med; 1986 Apr; 107(4):384-92. PubMed ID: 2420911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential ability of agonists to express distinct pools of fibrinogen (GpIIb/IIIa) receptors which can mediate the aggregation of human platelets.
    Watts IS; Keery RJ; Lumley P
    Thromb Haemost; 1989 Nov; 62(3):955-61. PubMed ID: 2512682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of platelet fibrinogen receptors on intact and proteolytically-treated platelets by use of an anti-glycoprotein IIIa monoclonal antibody (MA 123).
    Kornecki E; Lee H; Merlin F; Hershock D; Tuszynski GP; Niewiarowski S
    Thromb Res; 1984 Apr; 34(1):35-49. PubMed ID: 6328693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.
    Coller BS; Peerschke EI; Scudder LE; Sullivan CA
    J Clin Invest; 1983 Jul; 72(1):325-38. PubMed ID: 6308050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversible activation defect of the platelet glycoprotein IIb-IIIa complex in patients with uremia.
    Benigni A; Boccardo P; Galbusera M; Monteagudo J; De Marco L; Remuzzi G; Ruggeri ZM
    Am J Kidney Dis; 1993 Nov; 22(5):668-76. PubMed ID: 8238012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
    Gartner TK; Bennett JS
    J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arginyl-glycyl-aspartyl (RGD) epitope of human apolipoprotein (a) inhibits platelet aggregation by antagonizing the IIb subunit of the fibrinogen (GPIIb/IIIa) receptor.
    Barre DE
    Thromb Res; 2007; 119(5):601-7. PubMed ID: 16860375
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation.
    Shattil SJ; Hoxie JA; Cunningham M; Brass LF
    J Biol Chem; 1985 Sep; 260(20):11107-14. PubMed ID: 2411729
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex.
    Coller BS
    J Clin Invest; 1985 Jul; 76(1):101-8. PubMed ID: 2991335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synergistic action of two murine monoclonal antibodies that inhibit ADP-induced platelet aggregation without blocking fibrinogen binding.
    Newman PJ; McEver RP; Doers MP; Kunicki TJ
    Blood; 1987 Feb; 69(2):668-76. PubMed ID: 3026525
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
    Bennett JS; Hoxie JA; Leitman SF; Vilaire G; Cines DB
    Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Whole blood platelet aggregation in uremic dogs.
    Forsythe LT; Jackson ML; Meric SM
    Am J Vet Res; 1989 Oct; 50(10):1754-7. PubMed ID: 2802308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apoprotein (A) antagonises THE GPIIB/IIIA receptor on collagen and adp-stimulated human platelets.
    Barre DE
    Front Biosci; 2004 Jan; 9():404-10. PubMed ID: 14766377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet prostaglandin production and its implications.
    Smith JB; Ingerman CM; Silver MJ
    Adv Prostaglandin Thromboxane Res; 1976; 2():747-53. PubMed ID: 983875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that a collagen derived octapeptide inhibits fibrinogen binding to platelets stimulated by collagen and not by ADP.
    Pintigny D; Legrand C; Karniguian A; Legrand YJ; Caen JP
    Biochem Biophys Res Commun; 1985 Apr; 128(2):547-53. PubMed ID: 3994711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a unique type of thrombopathy of human platelets: defect in the exposure of active fibrinogen receptors in a patient with Friedreich's ataxia.
    Kornecki E; Cooper BA; Ehrlich YH
    J Lab Clin Med; 1988 Jun; 111(6):618-26. PubMed ID: 2836536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of action of the antiplatelet peptide, arietin, from Bitis arietans venom.
    Huang TF; Wang WJ; Teng CM; Ouyang C
    Biochim Biophys Acta; 1991 May; 1074(1):144-50. PubMed ID: 2043664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.